The mystery of ibogaine: can an African psychedelic cure addiction?

Copyright Omni Publications International Ltd. 1993 Omni July, 1993 SECTION: Vol. 15 ; No. 9 ; Pg. 14; ISSN: 0149-8711 LENGTH: 757 words HEADLINE: The mystery of ibogaine: can an African psychedelic cure addiction? BYLINE: Nadis, Steve BODY: Wild claims have been made about ibogaine, an hallucinogenic substance derived from …

Continue reading

Ibogaine and the FDA

NCTR 2002-2003 Research Plans – Neurotoxicology Title: Effects of Ibogaine on Neurotransmitter Systems, Generation of Free Radicals and Nitric Oxide Synthase Activity: Correlation with Neurohistological Evaluations in Mouse and Rat Brain Determine the effects of ibogaine on dopamine, serotonin and their metabolite concentrations in different regions of mouse and rat …

Continue reading

Ibogaine Patents @ the USPO

Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to …

Continue reading

Ibogaine Abstracts on PubMed

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC …

Continue reading

Seeking Ways to Crack Cocaine Addiction

Feature: Seeking Ways to Crack Cocaine Addiction The Lancet [Volume 352, Number 9136] 17 October 1998 by Kelly Morris The use of cocaine, a highly addictive stimulant and euphoriant with few physical withdrawal symptoms, is increasing. Up to 10% of ever-users will become heavy users, particularly if they inject the …

Continue reading

Data Accrue on “Visionary” Agent to Interrupt Addiction

Science & Medicine: Data Accrue on “Visionary” Agent to Interrupt Addiction The Lancet [Volume 354, Number 9193] 27 November 1999 by Kelly Morris Few therapies exist for drug addiction, and unfortunately one agent that has shown promise– the plant alkaloid ibogaine–is mostly given in unsafe settings by addict self-help groups, …

Continue reading

An Array of New Drugs…

An Array of New Drugs Show Promise in Fighting Addiction by: Gautam Naik The Wall Street Journal — (July 15, 2002) Could people be inoculated against drug addictions the way they can against some infectious diseases? It may be possible. Despite disappointing past efforts to treat addictions with medicine, recent …

Continue reading

One-Step Cure for Addiction?

by Jerome Burne Focus Magazine / (July 2000) Beneath a brilliant vault of stars, a young man is sitting on a rug somewhere out in the South African veldt. But he only has eyes for the extraordinary parade of images inside his head. There is a tremor to his legs …

Continue reading

Addiction Treatment Strives for Legitimacy

by Brian Vastag Journal of the American Medical Association Vol. 288 No. 24, pp. 3096-3101, December 25, 2002 © 2002 American Medical Association. All rights reserved. Tabernanthe iboga, the West African source of ibogaine, used by some to treat addiction. New York — Some drugs are made in laboratories. Others, …

Continue reading

Ibogaine Therapy: A ‘Vast, Uncontrolled Experiment’

ADDICTION RESEARCH: Ibogaine Therapy: A ‘Vast, Uncontrolled Experiment’ by Brian Vastag (Science, Vol 308, Issue 5720, 345-346 , 15 April 2005) Despite potentially harsh side effects, an African plant extract is being tested in two public clinical trials — and many clandestine ones On a snowy President’s Day, an odd …

Continue reading